Session Description: Artificial intelligence (AI) is poised to disrupt and revolutionize medical fields via data-driven solutions to improve patient outcome. In this session, we’ll discuss how AI-based techniques impact and improve health care for single ventricle disease patients with opportunities including disease diagnosis using AI in cardiac imaging, AI-based electrogram analysis and monitoring, benefits of AI in digital pathology in histopathological analyses, AI in early symptom prediction and identification of high-risk patients, AI in clinical workflow augmentation and hospital optimization, and AI in drug and gene treatment development. We’ll also discuss how AI tools have the potential to suffer from a host of shortcomings, including an inapplicability outside of the training domain and bias and a complex evolving relationship between clinicians and AI tools.
Markus Rottmann, PhD, Northwestern University
Collin Stultz, MD, PhD, Massachusetts General Hospital, MIT
Jagmeet Singh, MD, PhD, Massachusetts General Hospital, Harvard University